Sarah Al-Hajali
Private Equity Investor chez Myrisoph Capital, Inc.
Profil
Sarah is an experienced C-suite executive with extensive regional experience in the GCC healthcare industry, having successfully lead a turnaround with attractive investor returns in her position as a CEO of the first private cord blood bank in the region in a JV with the largest European Stem Cell company.
Sarah is a Swedish-Romanian executive with a BSc in Chemical Engineering and a MSc in Biotechnology from Malardalens University in Sweden, as well as an MBA from the London Business School.
Postes actifs de Sarah Al-Hajali
| Sociétés | Poste | Début |
|---|---|---|
Myrisoph Capital, Inc.
 Myrisoph Capital, Inc. Investment ManagersFinance Myrisoph Capital, Inc. (Myrisoph Capital) is an independent private equity and venture capital firm founded in 2016. The firm is headquartered in Los Angeles, California. | Private Equity Investor | 01/12/2016 |
Formation de Sarah Al-Hajali
| London Business School | Masters Business Admin |
| University of Stockholm | Graduate Degree |
| Mälardalen University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Myrisoph Capital, Inc.
Myrisoph Capital, Inc. Investment ManagersFinance Myrisoph Capital, Inc. (Myrisoph Capital) is an independent private equity and venture capital firm founded in 2016. The firm is headquartered in Los Angeles, California. | Finance |
